Information  X 
Enter a valid email address

Elsevier & ScienceDirect (REL)

  Print      Mail a friend       Annual reports

Tuesday 06 January, 2009

Elsevier & ScienceDirect

Elsevier to Include Doyma Spanish Medical Colle...





AMSTERDAM, January 6 /PRNewswire/ --     Elsevier, the world's leading publisher
of scientific, technical and
medical information products and services, announced today that fifty
prestigious titles from the Elsevier Doyma Spanish Medical Collection are
available on ScienceDirect, its online scientific research platform.



    Doyma, the leading Spanish language medical publisher acquired by
Elsevier in 2005, publishes approximately 5,000 high quality papers every
year. The inclusion of Elsevier Doyma titles on ScienceDirect will allow more
researchers across the world to access these articles.



    To date, the Elsevier Doyma collection has only been available through
http://www.doyma.es and http://www.elsevierinstituciones.com and the narrow
distribution as well as Spanish language nature of these platforms has
limited access. The thousands of authors represented in the Elsevier Doyma
collection will now enjoy greater market visibility, increasing the potential
for research collaboration and recognition. In addition, many of the articles
will now include English abstracts benefiting non-Spanish speaking
researchers.



    "The Elsevier Doyma Spanish Medical Collection represents a wide range of
high-quality journals," commented Rafael Sidi, Vice President, Product
Management, ScienceDirect. "We are excited to include these titles on
ScienceDirect giving them more visibility in the global research community."



    The addition of the Spanish Medical Collection follows the successful
launch of Elsevier's Masson French Medical titles early 2008 and contributes
to the evolution of the ScienceDirect platform into a comprehensive and
complete source of global scientific knowledge.



About ScienceDirect

    Over a quarter of the world's full text scientific, technical and medical
(STM) peer-reviewed articles - managed by renowned editors, written by
respected authors and read by researchers from around the globe - are
available in one place: ScienceDirect.



    Elsevier's extensive and unique full-text collection covers authoritative
titles from the core scientific literature including high impact factor
titles such as THE LANCET, Cell and Tetrahedron. Over nine million articles
are available online, including Articles in Press which offer online access
to recently accepted manuscripts. The critical mass of trusted information
available on ScienceDirect is unsurpassed. Coverage includes over 2,500
journals published by Elsevier and dynamic linking to journals from
approximately 2,000 STM publishers through CrossRef. An expanding program of
online major reference works, handbooks, book series and over 4,400 eBooks in
all fields of science seamlessly interlinks with primary research referenced
in journal articles.



About Elsevier

    Elsevier is a world-leading publisher of scientific, technical and 
medical information products and services. Working in partnership with the 
global science and health communities, Elsevier's 7,000 employees in over 70 
offices worldwide publish more than 2,000 journals and 1,900 new books per 
year, in addition to offering a suite of innovative electronic products, 
such as ScienceDirect (http://www.sciencedirect.com/), MD Consult 
(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.



    Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).


    
    CONTACT: 

    Malkie Bernheim/ Melanie Nadeau
    Padilla Speer Beardsley
    +1-212-752-8338
    [email protected]/ [email protected]

a d v e r t i s e m e n t